The Yaz and Yasmin multidistrict litigation (MDL) in the U.S. District Court for the Southern District of Illinois continues to progress, according to Carey Danis & Lowe Yaz and Yasmin…
Read More
The Pradaxa multi-district litigation (MDL) met in early February for a status conference to discuss recent progress made in the discovery and deposition processes. According to Seth A. Katz, one…
Read More
In the Yaz, Yasmin, and Ocella multicounty litigation (MCL) in the Superior Court of New Jersey in Bergen County, the court filed a new case management order in mid-October. The…
Read More
In early September, a woman who suffered from a deep vein thrombosis (DVT) in her right leg two years ago filed a Yaz lawsuit. According to a recent article in…
Read More
The Yaz and Yasmin multidistrict litigation (MDL) convened for a status conference on September 4, 2013 in the U.S. District Court for the Southern District of Illinois. The court met…
Read More
In Australia, women who claim to have been injured by the contraceptive drugs Yaz and Yasmin, both developed and manufactured by Bayer, are in the beginning stages of filing a…
Read More
A settlement agreement has been reached between Bayer and plaintiffs who filed a Yaz and Yasmin lawsuit specifically citing gallbladder complications. The settlement agreement between the plaintiffs and Bayer, the…
Read More
According to a Reuters report published on March 4, Bayer allocated $1.5 billion last year as a legal fund for Yaz and Yasmin lawsuits. In anticipation of future settlements of…
Read More
On December 19, the U.S. Food and Drug Administration (FDA) released a safety announcement regarding the anticoagulant medicine known as Pradaxa. Pradaxa, known generically as dabigatran etexilate mesylate, is manufactured…
Read More
Though the drug manufacturer denies Pradaxa as a defective drug, the surmounting Pradaxa bleeding deaths, injuries, and lawsuits prove otherwise. Pradaxa was introduced onto the U.S. drug market in October…
Read More